FDAs Jumpstart Program: A Vital Tool to Accelerate Drug Approvals

International Journal of ChemTech Research - India
doi 10.20902/ijctr.2018.110903
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Sai Scientific Communications

Related search

2017 FDA Drug Approvals

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2018English

A New in Vivo Screening Paradigm to Accelerate Antimalarial Drug Discovery

PLoS ONE
Multidisciplinary
2013English

Orphan Drug Approvals in Europe: Historical Review and Trends

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Characteristics of Recent Generic Drug Approvals by the US Food and Drug Administration

JAMA network open
Medicine
2019English

The FDA's Definitions, Designations, and Drug Approvals: Too Daring?

The Lancet Haematology
Hematology
2018English

Implementation Research: An Efficient and Effective Tool to Accelerate Universal Health Coverage

International Journal of Health Policy and Management
Health Information ManagementManagementMonitoringHealth PolicyLeadershipHealthPolicyLaw
2019English

Evidence of Comparative Efficacy Should Have a Formal Role in European Drug Approvals

BMJ
2011English

FDA Town Hall: New Drug Approvals in Gastrointestinal Disease (2018-2019)

Gastroenterology
HepatologyGastroenterology
2020English

HHVSF: A Framework to Accelerate Drug-Based High-Throughput Virtual Screening on High-Performance Computers

Lecture Notes in Computer Science
Computer ScienceTheoretical Computer Science
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy